Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Angiotensin II receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0292 | 0.3715 | 0.5 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.0747 | 1 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.0747 | 1 | 1 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0292 | 0.3715 | 1 |
Echinococcus multilocularis | dihydropyrimidine dehydrogenase (NADP+) | 0.0292 | 0.3715 | 1 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | 0.0485 | 0.6385 | 1 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0497 | 0.655 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0747 | 1 | 1 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0292 | 0.3715 | 1 |
Trichomonas vaginalis | dihydropyrimidine dehydrogenase, putative | 0.0292 | 0.3715 | 0.5 |
Leishmania major | dihydroorotate dehydrogenase | 0.0747 | 1 | 0.5 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0747 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydroorotate dehydrogenase 2 | 0.0747 | 1 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0292 | 0.3715 | 0.5 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.0747 | 1 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0292 | 0.3715 | 0.5 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.0747 | 1 | 0.5 |
Brugia malayi | nuclear hormone receptor | 0.0485 | 0.6385 | 0.6385 |
Echinococcus granulosus | dihydropyrimidine dehydrogenase NADP | 0.0292 | 0.3715 | 1 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0292 | 0.3715 | 0.5 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.0747 | 1 | 0.5 |
Trichomonas vaginalis | dihydroorotate dehydrogenase, putative | 0.0292 | 0.3715 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0474 | 0.6238 | 0.977 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.0747 | 1 | 0.5 |
Brugia malayi | Zinc finger, C2H2 type family protein | 0.0292 | 0.3715 | 0.3715 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.0747 | 1 | 0.5 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0747 | 1 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0747 | 1 | 1 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.0747 | 1 | 0.5 |
Entamoeba histolytica | dihydropyrimidine dehydrogenase, putative | 0.0292 | 0.3715 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.35 uM | Inhibitory concentration of the compound that gave 50 percent displacement of specific binding of [3H]-AII (2 nM) to Angiotensin ll receptor | ChEMBL. | 2329553 |
IC50 (binding) | = 0.35 uM | Inhibitory concentration of the compound that gave 50 percent displacement of specific binding of [3H]-AII (2 nM) to Angiotensin ll receptor | ChEMBL. | 2329553 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.